FR2373280A1 - Nouvelle forme de presentation pharmaceutique de l'acide 3-n-pyrrolidino-4-phenoxy-5-sulfamylbenzoique et son procede de preparation - Google Patents

Nouvelle forme de presentation pharmaceutique de l'acide 3-n-pyrrolidino-4-phenoxy-5-sulfamylbenzoique et son procede de preparation

Info

Publication number
FR2373280A1
FR2373280A1 FR7736876A FR7736876A FR2373280A1 FR 2373280 A1 FR2373280 A1 FR 2373280A1 FR 7736876 A FR7736876 A FR 7736876A FR 7736876 A FR7736876 A FR 7736876A FR 2373280 A1 FR2373280 A1 FR 2373280A1
Authority
FR
France
Prior art keywords
pyrrolidino
phenoxy
active substance
preparation process
new form
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7736876A
Other languages
English (en)
French (fr)
Other versions
FR2373280B1 (de
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of FR2373280A1 publication Critical patent/FR2373280A1/fr
Application granted granted Critical
Publication of FR2373280B1 publication Critical patent/FR2373280B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FR7736876A 1976-12-07 1977-12-07 Nouvelle forme de presentation pharmaceutique de l'acide 3-n-pyrrolidino-4-phenoxy-5-sulfamylbenzoique et son procede de preparation Granted FR2373280A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762655331 DE2655331A1 (de) 1976-12-07 1976-12-07 Zubereitungsformen von 3-n-pyrrolidino-4-phenoxy-5-sulfamyl-benzoesaeure und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
FR2373280A1 true FR2373280A1 (fr) 1978-07-07
FR2373280B1 FR2373280B1 (de) 1980-06-20

Family

ID=5994862

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7736876A Granted FR2373280A1 (fr) 1976-12-07 1977-12-07 Nouvelle forme de presentation pharmaceutique de l'acide 3-n-pyrrolidino-4-phenoxy-5-sulfamylbenzoique et son procede de preparation

Country Status (15)

Country Link
JP (1) JPS5372815A (de)
AT (1) AT355216B (de)
AU (1) AU513409B2 (de)
BE (1) BE861608A (de)
DE (1) DE2655331A1 (de)
DK (1) DK542877A (de)
ES (1) ES464642A1 (de)
FR (1) FR2373280A1 (de)
GB (1) GB1569018A (de)
IE (1) IE46005B1 (de)
IL (1) IL53539A0 (de)
NL (1) NL7713392A (de)
NZ (1) NZ185855A (de)
PT (1) PT67370B (de)
ZA (1) ZA777204B (de)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0243891A2 (de) * 1986-04-29 1987-11-04 Hoechst-Roussel Pharmaceuticals Incorporated Schichtenstruktur für die Verabreichung von Chemikalien mit kontrollierter Abgaberate
EP0260236A1 (de) * 1986-08-26 1988-03-16 ASTA Pharma Aktiengesellschaft L-Dopa enthaltendes Arzneimittel
WO1996026197A1 (en) * 1995-02-22 1996-08-29 Hoechst Pharmaceuticals & Chemicals K.K. Amorphous piretanide, piretanide polymorphs, process for their preparation and their use

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1964504A1 (de) * 1968-12-24 1970-07-09 Leo Pharm Prod Ltd Arzneimittelzubereitung mit einem Gehalt an 3-Butylamino-4-phenoxy-5-sulfamyl-benzoesaeure und deren Salzen

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1964504A1 (de) * 1968-12-24 1970-07-09 Leo Pharm Prod Ltd Arzneimittelzubereitung mit einem Gehalt an 3-Butylamino-4-phenoxy-5-sulfamyl-benzoesaeure und deren Salzen

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0243891A2 (de) * 1986-04-29 1987-11-04 Hoechst-Roussel Pharmaceuticals Incorporated Schichtenstruktur für die Verabreichung von Chemikalien mit kontrollierter Abgaberate
EP0243891A3 (en) * 1986-04-29 1988-08-03 Hoechst-Roussel Pharmaceuticals Incorporated A laminar structure for administering a chemical at a controlled release rate
EP0260236A1 (de) * 1986-08-26 1988-03-16 ASTA Pharma Aktiengesellschaft L-Dopa enthaltendes Arzneimittel
WO1996026197A1 (en) * 1995-02-22 1996-08-29 Hoechst Pharmaceuticals & Chemicals K.K. Amorphous piretanide, piretanide polymorphs, process for their preparation and their use
US6096779A (en) * 1995-02-22 2000-08-01 Hoechst Pharmaceuticals & Chemicals K.K. Amorphous piretanide, piretanide polymorphs, process for their preparation and their use

Also Published As

Publication number Publication date
ATA873777A (de) 1979-07-15
NZ185855A (en) 1979-10-25
DE2655331A1 (de) 1978-06-08
ES464642A1 (es) 1978-09-01
AU513409B2 (en) 1980-11-27
JPS5372815A (en) 1978-06-28
BE861608A (fr) 1978-06-07
AT355216B (de) 1980-02-25
GB1569018A (en) 1980-06-11
IE46005L (en) 1978-06-07
DK542877A (da) 1978-06-08
IL53539A0 (en) 1978-03-10
ZA777204B (en) 1978-10-25
AU3127477A (en) 1979-06-14
PT67370A (de) 1978-01-01
FR2373280B1 (de) 1980-06-20
IE46005B1 (en) 1983-01-26
NL7713392A (nl) 1978-06-09
PT67370B (de) 1979-09-20

Similar Documents

Publication Publication Date Title
US4804674A (en) Vaginal pharmaceutical composition
UY25067A1 (es) Acetato de sertralina, composiciones farmacéuticas que lo contienen y procedimientos de preparación.
BE901994A (fr) Comprimes de principes actifs pharmaceutiques a delitement rapide, stables au stockage.
CA2191129C (fr) Medicaments a base de metronidazole ou d'un melange synergetique de metronidazole et de clindamycine
Cho et al. Doxycycline is neuroprotective against nigral dopaminergic degeneration by a dual mechanism involving MMP-3
LeVeen et al. Combination of Evans blue with plasma protein: its significance in capillary permeability studies, blood dye disappearance curves, and its use as a protein tag
DE1222213B (de) Spermizides Praeparat
GB1399985A (en) Hardening microcapsule walls
TNSN98019A1 (fr) Derives d'acide arylsulfonylaminohydroxamique, procede pour leur preparation et compositions pharmaceutiques les contenant.
ES2117642T3 (es) Preparado farmaceutico que contiene n-glicofuroles y n-etilen glicoles.
FR2415112A1 (fr) Nouveaux derives spirothienohydantoines et composition pharmaceutique les contenant
FR2408345A1 (fr) Nouvelle composition a action anti-conceptionnelle
TNSN98025A1 (fr) Derives d'acide arylsulfonylhydroxamique, procede pour leur preparation et compositions les contenant.
MC2094A1 (fr) Medicament contenant de l'acide dihydrolipoique en tant que substance active,procede de preparation
BE904476A (fr) Solutions a base de phenytoine, leur procede de preparation et leur application pharmaceutique.
FR2381521A1 (fr) Base pour des preparations medicamenteuses a usage externe, preparation medicamenteuses preparees a l'aide de celle-ci et procede pour leur preparation
PT97300A (pt) Processo para a preparacao de esteres de acidos 1,4-di-hidropiridinocarboxilicos n-alquilados e de medicamentos que os contem
FR2541115B1 (fr) Medicament renfermant un peptide en tant que principe actif pour le traitement des affections ulcereuses
FR2461499A1 (fr) Composition pharmaceutique a base d'extraits de myrtille
FR2373280A1 (fr) Nouvelle forme de presentation pharmaceutique de l'acide 3-n-pyrrolidino-4-phenoxy-5-sulfamylbenzoique et son procede de preparation
BE752813A (fr) Preparation d'acide trans-chrysanthemique optiquement actif
FR2598320B1 (fr) Compositions pharmaceutiques hydrosolubles contenant de l'ubiquinone en tant que principe actif, utiles dans differentes applications therapeutiques
TNSN01115A1 (fr) Composition en particules contenant de l'eletriptan, et procede pour sa production
Abdul-Ghani et al. Effects of anticonvulsants on the in vivo and in vitro release of GABA
FR2358159A1 (fr) Le diamide de l'acide 2-(2-acetamido-2-deoxy-3 - o-d-glucopyranosyl) - d-propionyl-l-alanyl-d-glutamique et medicaments le contenant

Legal Events

Date Code Title Description
TP Transmission of property
CC Supplementary protection certificate (spc) laid open to the public (law of 25 june 1990)

Free format text: 92C0306, 920526

CB Supplementary protection certificate (spc) granted (law of 25 june 1990)

Free format text: 92C0306, 771207

CL Concession to grant licences